Neeland, Ian J.

Obesity and cardiovascular disease: a scientific statement from the American Heart Association

Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation

Cardiovascular Disease and AdiposityCardiovascular Function and Risk Factors

Cited by 3,691

Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, C. E., Rangaswami, J., Chow, S. L., Neeland, I. J., Tuttle, K. R., Khan, S. S., Coresh, J., Mathew, R. O., Baker-Smith, C. M., Carnethon, M. R., et al. (2023) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes

Cited by 2,208

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity

Ross, R., Neeland, I. J., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., Cuevas, A., Hu, F. B., et al. (2020) · Nature Reviews Endocrinology

Diabetes, Cardiovascular Risks, and LipoproteinsBody Composition Measurement Techniques

Cited by 1,966

Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement

Neeland, I. J., Ross, R., Després, J.-P., Matsuzawa, Y., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., et al. (2019) · The Lancet Diabetes & Endocrinology

Cardiovascular Disease and AdiposityDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,603

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association

Ndumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., Coresh, J., Baker-Smith, C. M., Carnethon, M. R., Després, J.-P., et al. (2023) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes

Cited by 1,405

HDL cholesterol efflux capacity and incident cardiovascular events

Rohatgi, A., Khera, A., Berry, J. D., Givens, E. G., Ayers, C. R., Wedin, K. E., Neeland, I. J., Yuhanna, I. S., Rader, D. R., de Lemos, J. A., et al. (2014) · New England Journal of Medicine

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 1,390

Development and validation of the American Heart Association’s PREVENT equations

Khan, S. S., Matsushita, K., Sang, Y., Ballew, S. H., Grams, M. E., Surapaneni, A., Blaha, M. J., Carson, A. P., Chang, A. R., Ciemins, E., et al. (2024) · Circulation

Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

Cited by 1,234

Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management

Neeland, I. J., Poirier, P., & Després, J.-P. (2018) · Circulation

Cardiovascular Disease and AdiposityDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 881

Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association

Khan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation

Health Promotion and Cardiovascular PreventionDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 797

Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults

Neeland, I. J., Ayers, C. R., Rohatgi, A. K., Turer, A. T., Berry, J. D., Das, S. R., Vega, G. L., Khera, A., McGuire, D. K., Grundy, S. M., et al. (2013) · Obesity

Cardiovascular Disease and AdiposityAdipokines, Inflammation, and Metabolic Diseases

Cited by 497

Metabolic syndrome

Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 463

Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies

Neeland, I. J., Linge, J., & Birkenfeld, A. L. (2024) · Diabetes, Obesity and Metabolism

Nutrition and Health in AgingDiet and metabolism studies

Cited by 391

Liraglutide for weight management: a critical review of the evidence

Mehta, A., Marso, S. P., & Neeland, I. J. (2017) · Obesity Science & Practice

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 311

The CardioMetabolic Health Alliance

Sperling, L. S., Mechanick, J. I., Neeland, I. J., Herrick, C. J., Després, J.-P., Ndumele, C. E., Vijayaraghavan, K., Handelsman, Y., Puckrein, G. A., Araneta, M. R. G., et al. (2015) · Journal of the American College of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

Cited by 294

The Relationship of Body Mass and Fat Distribution With Incident Hypertension

Chandra, A., Neeland, I. J., Berry, J. D., Ayers, C. R., Rohatgi, A., Das, S. R., Khera, A., McGuire, D. K., de Lemos, J. A., & Turer, A. T. (2014) · Journal of the American College of Cardiology

Blood Pressure and Hypertension StudiesCardiovascular Disease and Adiposity

Cited by 264

Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial

Neeland, I. J., Marso, S. P., Ayers, C. R., Lewis, B., Oslica, R., Francis, W., Rodder, S., Pandey, A., & Joshi, P. H. (2021) · The Lancet Diabetes & Endocrinology

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 202

Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?

Linge, J., Birkenfeld, A. L., & Neeland, I. J. (2024) · Circulation

Nutrition and Health in AgingDiabetes Treatment and Management

Cited by 180

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

Neeland, I. J., McGuire, D. K., Chilton, R., Crowe, S., Lund, S. S., Woerle, H. J., Broedl, U. C., & Johansen, O. E. (2016) · Diabetes and Vascular Disease Research

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 168

Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial

Sattar, N., Neeland, I. J., Dahlqvist Leinhard, O., Fernández Landó, L., Bray, R., Linge, J., & Rodriguez, A. (2025) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementNutrition and Health in Aging

Cited by 131

The impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: an exploratory analysis of the EMPA-REG OUTCOME trial

Neeland, I. J., Eliasson, B., Kasai, T., Marx, N., Zinman, B., Inzucchi, S. E., Wanner, C., Zwiener, I., Wojeck, B. S., Yaggi, H. K., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementObstructive Sleep Apnea Research

Cited by 93

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome

Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC

Diabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes

Cited by 90

Effects of weight-loss medications on cardiometabolic risk profiles: a systematic review and network meta-analysis

Khera, R., Pandey, A., Chandar, A. K., Murad, M. H., Prokop, L. J., Neeland, I. J., Berry, J. D., Camilleri, M., & Singh, S. (2018) · Gastroenterology

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 90

Management of Obesity in Cardiovascular Practice

Després, J.-P., Carpentier, A. C., Tchernof, A., Neeland, I. J., & Poirier, P. (2021) · Journal of the American College of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 87

Metabolic Effects of Exercise Training Among Fitness-Nonresponsive Patients With Type 2 Diabetes: The HART-D Study

Pandey, A., Swift, D. L., McGuire, D. K., Ayers, C. R., Neeland, I. J., Blair, S. N., Johannsen, N., Earnest, C. P., Berry, J. D., & Church, T. S. (2015) · Diabetes Care

Cardiovascular and exercise physiologyPhysical Activity and Health

Cited by 83